Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)

Chen Liu, Yongpeng Ji, Xiaoyan Wu, Brenda Cerqueira, David Cade, Peng Du, Zhi Yang

Open source

DOI: 10.1186/s13550-025-01332-5
Published: 2025-12-24
Container: EJNMMI Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13550-025-01332-5,
  title = {Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)},
  author = {Chen Liu and Yongpeng Ji and Xiaoyan Wu and Brenda Cerqueira and David Cade and Peng Du and Zhi Yang},
  year = {2025},
  journal = {EJNMMI Research},
  doi = {10.1186/s13550-025-01332-5},
  url = {https://doi.org/10.1186/s13550-025-01332-5}
}

RIS

TY  - JOUR
TI  - Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)
AU  - Chen Liu
AU  - Yongpeng Ji
AU  - Xiaoyan Wu
AU  - Brenda Cerqueira
AU  - David Cade
AU  - Peng Du
AU  - Zhi Yang
PY  - 2025
JO  - EJNMMI Research
DO  - 10.1186/s13550-025-01332-5
UR  - https://doi.org/10.1186/s13550-025-01332-5
ER  -

APA

Liu, C., Ji, Y., Wu, X., Cerqueira, B., Cade, D., Du, P., & Yang, Z. (2025). Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP). EJNMMI Research. https://doi.org/10.1186/s13550-025-01332-5

Source records

crossref · retrieved 2026-09-25T18:00:09.139Z